HeartSciences Inc. reported that as of May 14, 2025, it has received an extension from Nasdaq to regain compliance with its minimum stockholders’ equity requirement of $2.5 million by September 15, 2025, or risk delisting. The company is actively working to meet this requirement to maintain its Nasdaq listing.